Research links COVID-19 to Rise in Childhood Type 1 Diabetes.

         This is clinical trial results from 30 youngsters in London clinics diagnosed with onset type 1 diabetes during this dangerous COVID pandemic. 

             Cases of type 1 diabetes among children in a small UK study almost doubled during the peak of Britain’s COVID-19 epidemic, suggesting a possible link between the two diseases that need more investigation, scientists said.
Type 1 diabetes cases among kids in the small UK nearly multiplied during the threshold of Britain's COVID-19 pandemic, recommending a potential connection between the two ailments that need more examination, researchers said.
       "Our investigation shows that during the threshold of the pandemic the number of new cases of type 1 diabetes in youngsters was strangely high in two of the medical clinics (we examined) contrasted with earlier years," said Karen Logan, who leads this analysis. 

        "At the point when we examined further, out of these some kids had already suffered from COVID or had recently been positive to the virus," Logan said past reports from China and Italy had noticed that kids were being diagnosed in clinics to have new-onset type 1 diabetes during the pandemic. 

    This investigation, distributed in the Diabetes Care journal, broke down information from 30 youngsters in London clinics determined to have new-onset type 1 diabetes during the first threshold of the pandemic — around double of the cases found in this period in the past years. Twenty-one of the kids were positive for COVID-19 or had antibody tests to see whether they had been presented to the infection—and five resulted positive for novel COVID contamination. Type 1 diabetes causes insulin-creating cells in the pancreas to be killed, keeping the body from delivering enough insulin to manage glucose levels. The Imperial group said one potential clarification may be that the novel Covid's spike protein may tamper insulin-production cells in the pancreas. 
      "More exploration is expected to build up whether there is a complete connection … yet meanwhile we trust clinicians will be aware of this," Logan said.